Total Payments
$3,691
2024 Payments
$768.64
Companies
21
Transactions
178
Medicare Patients
5,599
Medicare Billing
$706,044
Payment Breakdown by Category
Food & Beverage$3,671 (99.5%)
Education$19.91 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,671 | 177 | 99.5% |
| Education | $19.91 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $652.92 | 33 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $504.79 | 32 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $389.73 | 20 | $0 (2024) |
| Abbott Laboratories | $318.09 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $290.25 | 14 | $0 (2024) |
| PFIZER INC. | $249.76 | 12 | $0 (2024) |
| Boston Scientific Corporation | $217.48 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $202.35 | 11 | $0 (2024) |
| Merck Sharp & Dohme LLC | $190.07 | 11 | $0 (2022) |
| Novo Nordisk Inc | $164.86 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $768.64 | 33 | Boston Scientific Corporation ($165.79) |
| 2023 | $627.36 | 29 | Janssen Pharmaceuticals, Inc ($112.08) |
| 2022 | $645.04 | 31 | Bayer HealthCare Pharmaceuticals Inc. ($145.95) |
| 2021 | $552.27 | 29 | Janssen Pharmaceuticals, Inc ($176.79) |
| 2020 | $202.03 | 10 | Novartis Pharmaceuticals Corporation ($62.44) |
| 2019 | $181.65 | 11 | Janssen Pharmaceuticals, Inc ($34.14) |
| 2018 | $241.00 | 8 | Abbott Laboratories ($135.04) |
| 2017 | $472.56 | 27 | Novartis Pharmaceuticals Corporation ($191.21) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $3.44 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.76 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $28.73 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/14/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/31/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Cardiovascular | ||||||
| 09/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/29/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.19 | General |
| Category: Cardiovascular | ||||||
| 08/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $37.50 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 07/16/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $37.50 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Obesity | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/30/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.19 | General |
| Category: Cardiovascular | ||||||
| 04/18/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $31.43 | General |
| Category: CARDIOLOGY | ||||||
| 04/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/04/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,541 | 3,162 | $369,015 | $208,876 |
| 2022 | 17 | 1,504 | 2,902 | $333,820 | $178,464 |
| 2021 | 18 | 1,343 | 2,421 | $284,105 | $156,900 |
| 2020 | 17 | 1,211 | 2,477 | $300,693 | $161,805 |
Total Patients
5,599
Total Services
10,962
Medicare Billing
$706,044
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 16 | 16 | $10,480 | $5,821 | 55.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 464 | 604 | $6,064 | $4,071 | 67.1% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 14 | 71 | $7,455 | $3,823 | 51.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 32 | 32 | $6,365 | $3,478 | 54.6% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 16 | 32 | $7,130 | $2,854 | 40.0% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 19 | 19 | $4,750 | $2,561 | 53.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 21 | 29 | $5,445 | $2,340 | 43.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 18 | 18 | $4,455 | $2,041 | 45.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $4,930 | $1,667 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 26 | $3,380 | $1,502 | 44.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 11 | 17 | $2,210 | $954.51 | 43.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 17 | 17 | $1,860 | $774.37 | 41.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 38 | 41 | $1,025 | $419.05 | 40.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 22 | 39 | $390.00 | $115.41 | 29.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 227 | 1,007 | $103,656 | $60,236 | 58.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 79 | 81 | $22,810 | $13,526 | 59.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 110 | 117 | $21,658 | $13,103 | 60.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 82 | 149 | $21,840 | $12,815 | 58.7% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2021 | 24 | 24 | $16,800 | $9,382 | 55.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 101 | $18,135 | $9,177 | 50.6% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 145 | 149 | $16,381 | $8,526 | 52.0% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 34 | 34 | $10,200 | $5,057 | 49.6% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2021 | 23 | 46 | $10,580 | $4,337 | 41.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 64 | $9,135 | $4,087 | 44.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 13 | 54 | $5,522 | $3,102 | 56.2% |
About Dr. Nelson Aguilar, MD
Dr. Nelson Aguilar, MD is a Cardiovascular Disease healthcare provider based in Lauderhill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1760687842.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nelson Aguilar, MD has received a total of $3,691 in payments from pharmaceutical and medical device companies, with $768.64 received in 2024. These payments were reported across 178 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,671).
As a Medicare-enrolled provider, Aguilar has provided services to 5,599 Medicare beneficiaries, totaling 10,962 services with total Medicare billing of $706,044. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Internal Medicine
- Location Lauderhill, FL
- Active Since 06/18/2007
- Last Updated 03/19/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760687842
Products in Payments
- XARELTO (Drug) $590.28
- ELIQUIS (Drug) $476.22
- ENTRESTO (Drug) $468.27
- Kerendia (Drug) $290.25
- WATCHMAN FLX (Device) $165.79
- FARXIGA (Drug) $164.69
- JARDIANCE (Drug) $144.09
- Ozempic (Drug) $140.86
- VERQUVO (Drug) $139.18
- Mitra Clip system (Device) $135.04
- CRT-Ds (Device) $115.24
- CAMZYOS (Drug) $109.34
- LifeVest (Device) $100.70
- INVOKANA (Drug) $62.64
- Barostim Neo System (Device) $54.44
- JANUVIA (Drug) $50.89
- BRILINTA (Drug) $37.66
- LEQVIO (Drug) $36.52
- CHANTIX (Drug) $32.10
- VITALPATCH RTM (Device) $31.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.